The Asian Transcatheter Aortic Valve Replacement Registry

Seung-Jung Park1,505 enrolled

Overview

The purpose of this study is to evaluate the clinical outcomes of transcatheter aortic valve replacement (TAVR) in the Asian Pacific population

This registry changes to TP-TAVR registry(NCT03826264). Some subjects moved to TP-TAVR registry and continue to 10-year follow-up.

Study Type

OBSERVATIONAL

Enrollment

1,505

Conditions

Aortic Valve Stenosis Aortic Diseases

Interventions

transcatheter aortic valve replacementDEVICE

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with symptomatic severe aortic stenosis who are not candidates for surgical aortic valve replacement because of coexisting illnesses * The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site

Locations (12)

Queen Elizabeth Hospital

Hong Kong, China

Shonan Kamakura General Hospital

Kamakura, Japan

Kokura Memorial Hospital

Kitakyushu, Japan

Outcomes

Primary Outcomes

Death

Time frame: 1 month

Death

Time frame: 6 months

Death

Time frame: 1 year

Death

Time frame: 2 years

Death

Time frame: 3 years

Death

Time frame: 4 years

Death

Time frame: 5 years

Secondary Outcomes

Death from cardiac cause

Time frame: 1 month

Death from cardiac cause

Time frame: 6 months

Death from cardiac cause

Time frame: 1 year

Death from cardiac cause

Time frame: 2 years

Death from cardiac cause

Time frame: 3 years

Death from cardiac cause

Time frame: 4 years

Death from cardiac cause

Time frame: 5 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.